Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaki Terabe

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Journal of Virology|August 22, 2006
Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic miceTakahiro Okazaki, Masaki Terabe, Andrew T Catanzaro, et al.
International Journal of Cancer|November 4, 2004
Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13Jong Myun Park, Masaki Terabe, Leon T van den Broeke, et al.
International Journal of Cancer|October 16, 2009
Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cellsShun Takaku, Masaki Terabe, Elena Ambrosino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
IL-15 expands unconventional CD8alphaalphaNK1.1+ T cells but not Valpha14Jalpha18+ NKT cellsMasaki Terabe, Yutaka Tagaya, Qing Zhu, et al.
The Journal of Clinical Investigation|August 18, 2004
Progress on new vaccine strategies against chronic viral infectionsJay A Berzofsky, Jeffrey D Ahlers, John Janik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomasJong Myun Park, Masaki Terabe, Yoshio Sakai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependentSuzanne Ostrand-Rosenberg, Virginia K Clements, Masaki Terabe, et al.
Frontiers in Oncology|May 27, 2021
Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of GlioblastomaStephen C Frederico, John C Hancock, Emily E S Brettschneider, et al.
Cancer Research|March 15, 2008
Therapy of advanced established murine breast cancer with a recombinant adenoviral ErbB-2/neu vaccineJong Myun Park, Masaki Terabe, Jason C Steel, et al.
Vaccine|July 3, 2007
The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protectionAntoun Toubaji, Sarah Hill, Masaki Terabe, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Journal of Virology|August 22, 2006
Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic miceTakahiro Okazaki, Masaki Terabe, Andrew T Catanzaro, et al.
International Journal of Cancer|November 4, 2004
Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13Jong Myun Park, Masaki Terabe, Leon T van den Broeke, et al.
International Journal of Cancer|October 16, 2009
Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cellsShun Takaku, Masaki Terabe, Elena Ambrosino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
IL-15 expands unconventional CD8alphaalphaNK1.1+ T cells but not Valpha14Jalpha18+ NKT cellsMasaki Terabe, Yutaka Tagaya, Qing Zhu, et al.
The Journal of Clinical Investigation|August 18, 2004
Progress on new vaccine strategies against chronic viral infectionsJay A Berzofsky, Jeffrey D Ahlers, John Janik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomasJong Myun Park, Masaki Terabe, Yoshio Sakai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependentSuzanne Ostrand-Rosenberg, Virginia K Clements, Masaki Terabe, et al.
Frontiers in Oncology|May 27, 2021
Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of GlioblastomaStephen C Frederico, John C Hancock, Emily E S Brettschneider, et al.
Cancer Research|March 15, 2008
Therapy of advanced established murine breast cancer with a recombinant adenoviral ErbB-2/neu vaccineJong Myun Park, Masaki Terabe, Jason C Steel, et al.
Vaccine|July 3, 2007
The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protectionAntoun Toubaji, Sarah Hill, Masaki Terabe, et al.
Pageof 9